Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

M-084

Supelco

Modafinil solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Formule empirique (notation de Hill):
C15H15NO2S
Numéro CAS:
Poids moléculaire :
273.35
Numéro CE :
Code UNSPSC :
41116107
Nomenclature NACRES :
NA.24

Qualité

certified reference material

Forme

liquid

Caractéristiques

Snap-N-Spike®/Snap-N-Shoot®

Conditionnement

ampule of 1 mL

Fabricant/nom de marque

Cerilliant®

Concentration

1.0 mg/mL in acetonitrile

Technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

Application(s)

forensics and toxicology

Format

single component solution

Température de stockage

−20°C

Chaîne SMILES 

NC(=O)CS(=O)C(c1ccccc1)c2ccccc2

InChI

1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)

Clé InChI

YFGHCGITMMYXAQ-UHFFFAOYSA-N

Informations sur le gène

human ... SLC6A3(6531)

Description générale

An analeptic drug approved by the US FDA for the treatment of narcolepsy, shift work sleep disorder, and excessive daytime sleepiness. This well known nootropic drug, also known as Provigil® or Modavigil®, is often used as a performance-enhancing drug in academics and sports.

Application


  • Innovative Spectrofluorimetric Method for Modafinil Determination: An innovative computationally designed-spectrofluorimetric method has been developed for the determination of modafinil in tablets and human plasma, leveraging the high-purity modafinil solution. This approach enhances analytical accuracy and is crucial for pharmacokinetic studies and neuropharmacological research, offering significant benefits for biochemistry experiments focused on cognitive enhancement and neurotransmitter studies (Hosny et al., 2022).

Produits recommandés

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

Informations légales

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Modavigil is a registered trademark of Cephalon, Inc.
Provigil is a registered trademark of Cephalon, Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Produit(s) apparenté(s)

Pictogrammes

FlameExclamation mark

Mention d'avertissement

Danger

Classification des risques

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2

Code de la classe de stockage

3 - Flammable liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

35.6 °F - closed cup

Point d'éclair (°C)

2 °C - closed cup


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Cognitive enhancers are set to change workplaces.
Jacqui Wise
BMJ (Clinical research ed.), 345, e7538-e7538 (2012-11-09)
Jared Bruce et al.
Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 25(3), 107-114 (2012-09-11)
Examine the efficacy of armodafinil in improving cognition in patients with multiple sclerosis (MS). Many patients with MS experience cognitive difficulties. Armodafinil has shown promise as a cognitive enhancer in other patient populations. No studies have examined whether armodafinil improves
Editorial: Cognitive enhancement: are we barking up the wrong tree?
Andrew Scholey et al.
Current drug abuse reviews, 5(4), 255-256 (2012-12-21)
Mei-Hong Qiu et al.
PloS one, 7(9), e45471-e45471 (2012-10-03)
We have previously shown that modafinil promotes wakefulness via dopamine receptor D(1) and D(2) receptors; however, the locus where dopamine acts has not been identified. We proposed that the nucleus accumbens (NAc) that receives the ventral tegmental area dopamine inputs
Trends in on-label and off-label modafinil use in a nationally representative sample.
Renée A Peñaloza et al.
JAMA internal medicine, 173(8), 704-706 (2013-04-05)

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique